Meridian Wealth Management, LLC Nektar Therapeutics Transaction History

Meridian Wealth Management, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 05, 2019	SELL	$30.43 - $56.65 $178,776 - $332,818	-5,875 Closed	0 $0
Q3 2018 Oct 19, 2018	BUY	$46.46 - $68.49 $929 - $1,369	20 Added 0.34%	5,875 $358,000
Q2 2018 Aug 06, 2018	BUY	$46.25 - $104.45 $270,793 - $611,554	5,855 New	5,855 $286,000

126

109M

150K

Ticker NKTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,404,992
Market Cap $259M
Description
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...

Get notified when there are updates to the investment portfolio of Meridian Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Meridian Wealth Management, LLC with notifications on news.